{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:23:03Z","timestamp":1777497783155,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773609"],"award-info":[{"award-number":["81773609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573322"],"award-info":[{"award-number":["81573322"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Program of Yunling Scholarship"},{"name":"CAS Hundred Talents Program"},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association, CAS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Applied Basic Research Programs of Yunnan Province","award":["2017FB137"],"award-info":[{"award-number":["2017FB137"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejmech.2018.07.027","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T20:35:31Z","timestamp":1531254931000},"page":"381-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Synthesis and biological evaluation of magnolol derivatives as melatonergic receptor agonists with potential use in depression"],"prefix":"10.1016","volume":"156","author":[{"given":"Tong-Hua","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Bao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-An","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Xiu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Ze","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.07.027_bib1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.ejmech.2018.07.027_bib2","series-title":"World Health Organization (WHO) Website: fact Sheet on Depression","year":"2017"},{"key":"10.1016\/j.ejmech.2018.07.027_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2018.07.027_bib4","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1517\/13543784.16.9.1365","article-title":"Triple uptake inhibitors: therapeutic potential in depression and beyond","volume":"16","author":"Chen","year":"2007","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2018.07.027_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/026988110001400101","article-title":"Evidence-based guide-lines for treating depressive disorders with antidepressants: a revision of the 1993 British association for psychopharmacology guidelines","volume":"14","author":"Anderson","year":"2000","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.ejmech.2018.07.027_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0924-977X(02)00057-3","article-title":"The role of noradrenaline and selective noradrenaline reuptake inhibition in depression","volume":"12","author":"Brunello","year":"2002","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.ejmech.2018.07.027_bib7","first-page":"13","article-title":"Differences in mechanism of action between current and future antidepressants","volume":"64","author":"Stahl","year":"2003","journal-title":"J.\u00a0Clin. Psychiatr."},{"key":"10.1016\/j.ejmech.2018.07.027_bib8","article-title":"Triple reuptake inhibitors as potential therapeutics for depression and other disorders: design paradigm and developmental challenges","author":"Subbaiah","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.027_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-079X.2011.00962.x","article-title":"Melatonin and its analogs in insomnia and depression","volume":"52","author":"Cardinali","year":"2012","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2018.07.027_bib10","first-page":"1","article-title":"Melatonergic drugs in clinical practice","volume":"58","author":"Hardeland","year":"2008","journal-title":"Arzneim-Forsch Drug Res."},{"key":"10.1016\/j.ejmech.2018.07.027_bib11","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2174\/138955707782110132","article-title":"Synthesis of compounds as melatonin agonists and antagonists","volume":"7","author":"Garratt","year":"2007","journal-title":"A.\u00a0Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.027_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/ml300235q","article-title":"Magnolia extract, magnolol and metabolites: activation of cannabinoid CB2 receptors and blockade of the related GPR55","volume":"4","author":"Rempel","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.07.027_bib13","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1007\/s11095-016-1953-x","article-title":"Methylation and esterification of magnolol for ameliorating cutaneous targeting and therapeutic index by topical application","volume":"33","author":"Lin","year":"2016","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.ejmech.2018.07.027_bib14","first-page":"9","article-title":"The importance of norepinephrine in depression","volume":"7","author":"Moret","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat"},{"key":"10.1016\/j.ejmech.2018.07.027_bib15","series-title":"Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","author":"Stahl","year":"2008"},{"key":"10.1016\/j.ejmech.2018.07.027_bib16","series-title":"Agomelatine, Melatonin and Depression: Melatonin, Neuroprotective Agents and Antidepressant Therapy","first-page":"229","author":"Norman","year":"2016"},{"key":"10.1016\/j.ejmech.2018.07.027_bib17","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.bmcl.2014.03.060","article-title":"Synthesis, structure-activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents","volume":"24","author":"Chen","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.07.027_bib18","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.bmcl.2015.02.024","article-title":"Isolation, synthesis and anti-hepatitis B virus evaluation of p-hydroxyacetophenone derivatives from Artemisia capillaris","volume":"25","author":"Zhao","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.07.027_bib19","doi-asserted-by":"crossref","first-page":"45059","DOI":"10.1039\/C6RA06748D","article-title":"Bioactivity-guided synthesis of tropine derivatives as new agonists for melatonin receptors","volume":"6","author":"Yin","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2018.07.027_bib20","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0024-3205(01)01498-9","article-title":"Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus","volume":"70","author":"Rodrigues","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2018.07.027_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.intimp.2017.10.001","article-title":"Senegenin exerts anti-depression effect in mice induced by chronic un-predictable mild stress via inhibition of NF-\u03baB regulating NLRP3 signal pathway","volume":"53","author":"Li","year":"2017","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2018.07.027_bib22","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejmech.2018.07.027_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"Behavioural despair in rats and mice: strain differences and the effects of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.07.027_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.ejmech.2018.07.027_bib25","first-page":"644","article-title":"Simultaneous detection of 8 monoamine neurotransmitters in different sections of rat brains with HPLC and coularray electrochemistry","volume":"33","author":"Deng","year":"2015","journal-title":"J.\u00a0Guangdong Med. Coll."},{"key":"10.1016\/j.ejmech.2018.07.027_bib26","series-title":"Environmental and Safety Monograph Series on Testing and Adjustment","author":"OECD Guideline on acute oral toxicity (AOT)","year":"2008"},{"key":"10.1016\/j.ejmech.2018.07.027_bib27","first-page":"217","article-title":"Acute and subacute toxic study of aqueous leaf extract of Combretum molle","volume":"11","author":"Yeo","year":"2012","journal-title":"Trop. J. Pharmaceut. Res."},{"key":"10.1016\/j.ejmech.2018.07.027_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jms.3929","article-title":"Identification and characterization of fluvastatin metabolites in rats by UHPLC\/Q-TOF\/MS\/MS and in silico toxicological screening of the metabolites","volume":"52","author":"Chavan","year":"2017","journal-title":"J.\u00a0Mass Spectrom."},{"key":"10.1016\/j.ejmech.2018.07.027_bib29","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1002\/bmc.4016","article-title":"Metabolic profiling of quercetin in rats using ultra-performance liquid chromatography\/quadrupole-time-of-flight mass spectrometry","volume":"12","author":"Wu","year":"2017","journal-title":"Biomed. Chromatogr."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830583X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830583X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T15:39:44Z","timestamp":1568993984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341830583X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":29,"alternative-id":["S022352341830583X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.07.027","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of magnolol derivatives as melatonergic receptor agonists with potential use in depression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}